| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cee095451050589fc5638041bf744324 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-065 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e7d01534bdb1c841b9386074b411f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168223b1c9df9361b4e159f323fa8f9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feca79076759dead51ed938f3d33ed0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b5d84ed2c67650adf308aed7625f934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a7e632770b6d457459c50bd0e1b4e2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82414d09e535aad3ebd63f77d60a547d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748524ed55685c9b08bf6bc46f204803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791e13cb29cdd34116f9c94721ef9737 |
| publicationDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2011010190-A |
| titleOfInvention |
IMMUNOMODULATING METALOPEPTIDES (IMMP) AND COMPOSITIONS THAT CONTAIN THEM. |
| abstract |
The present invention is related to the field of human and veterinary medicine. The problem that is solved with the invention is the lack of an agent that improves the immune response in immunosuppressed subjects or with autoimmunity problems, as well as with infections; decrease the effects of stress, fight tissue fibrosis; the need for anti inflammatory agents; of treatments for acute and chronic hepatitis; of treatments against malignant processes and metastases; as well as plaquetopenia, all in humans and animals. It consists of a molecular complex formed by a metal ion and a peptide as a novel compound, which is called "immunomodulatory metallopeptide" or "lmmunomodulator metallopeptide" in English and which we will abbreviate as "IMMP". The process for obtaining the complex, the use of the metallopeptide to produce a therapeutic or nutraceutical agent and the use of that agent in humans and animals are also included in the claims. |
| priorityDate |
2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |